|Articles|May 30, 2023

Cannabis Science Conference Fall Meeting Issues Call for Abstracts

Author(s)Grant Playter

The next Cannabis Science Conference Fall meeting is soliciting a call for abstracts.

MJH Life Sciences®, parent company of Pharmaceutical Technology® and BioPharm International®, is organizing the next Cannabis Science Conference Fall meeting in Providence, RI, which will run on Sept. 20–22, 2023. The conference is looking for speakers to share their knowledge on a variety of topics including analytical science, medical cannabis, cultivation, and psychedelics.

The event is currently soliciting a call for abstracts. Please submit your talks for consideration to the 2023 Cannabis Science Conference Fall Abstract Submission Portal at this link. The deadline to submit abstracts is June 2, 2023.


Related to this article

The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
Boehringer Ingelheim licenses six preclinical ADC and T-cell engager programs from Sino Biopharmaceutical in a deal worth up to $7 billion, Spyre Therapeutics drops anti-TL1A antibody SPY072 in rheumatic diseases after phase 2 misses and turns to hidradenitis suppurativa, and Biora Therapeutics gets ethics approval for a first-in-human trial of its BioJet oral adalimumab capsule.
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.